Friday March 25, 2022 - 5pm - Auditoire Maisin

Also on TEAMS :

https://teams.microsoft.com/l/meetup-join/19%3ameeting_N2MxODVlY2UtODY2OC00YWM3LWEzYjEtMzE2YTNjOGY4MTQ0%40thread.v2/0?context=%7b%22Tid%22%3a%227ab090d4-fa2e-4ecf-bc7c-4127b4d582ec%22%2c%22Oid%22%3a%228481296a-5a6e-427c-8c19-0b18c3e0de54%22%7d

Yasmine LABRAK - Advanced Drug Delivery and Biomaterials (ADDB) and Bioanalysis and Pharmacology of Bioactive Lipids (BPBL)

Targeted nanomedicines to stimulate the differentiation of oligodendrocyte progenitor cells in the scope of multiple sclerosis

Promotors : Anne des Rieux et Giulio Muccioli

Related publications :

• Labrak, Y., Heurtault, B., Frisch, B., Saulnier, P., Lepeltier, E., Miron, V. E., Muccioli, G. & Des Rieux, A. (2022). Impact of anti-PDGFRα antibody surface functionalization on LNC uptake by oligodendrocyte progenitor cells. International Journal of Pharmaceutics, 121623.
• Xu, Y*., Fourniols, T*., Labrak, Y*, Preat V. Beloqui A. & Des Rieux, A. (2022). Surface modification of lipid-based nanoparticles. Under revision in ACS Nano

*equal contribution

Info: anne.desrieux@uclouvain.be – giulio.muccioli@uclouvain.be